Related Experiment Videos
Endoscopist-Directed Propofol.
1Indiana University Hospital, Room 4100, 550 North University Boulevard, Indianapolis, IN 46202, USA.
Gastrointestinal Endoscopy Clinics of North America
|July 4, 2016
Summary
Endoscopist-directed propofol (EDP) offers a safe and cost-effective sedation method for endoscopy. Despite endorsement by US societies, its adoption in the US is hindered by financial, legal, and regulatory challenges.
Area of Science:
- Gastroenterology
- Anesthesiology
- Healthcare Management
Background:
- Endoscopist-directed propofol (EDP) involves propofol administration for endoscopic sedation solely under the endoscopist's supervision.
- This sedation method excludes the involvement of anesthesia specialists, such as anesthesiologists or nurse anesthetists.
Purpose of the Study:
- To evaluate the safety and cost-effectiveness of endoscopist-directed propofol (EDP) for endoscopic sedation.
- To understand the factors influencing the adoption and expansion of EDP in clinical practice.
Main Methods:
- The study reviews existing evidence on the safety and economic benefits of EDP compared to traditional anesthesia-provided sedation.
- Analysis of factors limiting EDP implementation in the United States, including financial, legal, and regulatory aspects.
Main Results:
- EDP has demonstrated a strong safety profile for endoscopic sedation.
- EDP presents a cost-effective alternative to sedation managed by anesthesia specialists.
- US gastroenterology societies endorse EDP as a suitable practice model.
Conclusions:
- Endoscopist-directed propofol (EDP) is a safe, cost-effective, and endorsed sedation strategy for endoscopy.
- Significant financial, medical-legal, and regulatory barriers impede the widespread adoption of EDP in the United States.